Gastroparesis Drugs Market Size 2024: Top Leaders, Report Analysis and Forecast 2032

IMARC Group, a leading market research company, has recently releases report titled "Gastroparesis Drugs Market Report by Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others), Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections), Distribution Channel (Hospitals and Clinics, Pharmacies, Online Stores), and Region 2024-2032." The study provides a detailed analysis of the industry, including the global gastroparesis drugs market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the gastroparesis drugs market?

The global gastroparesis drugs market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032.

Request for a PDF sample of this report: https://www.imarcgroup.com/gastroparesis-drugs-market/requestsample

What is Gastroparesis Drugs?

Gastroparesis, or partial paralysis, is a medical disorder wherein the natural and spontaneous stomach motility and muscles are negatively impacted, and it disrupts the digestive process. If it is not treated, then causes nausea, vomiting, stomach discomfort, and problems with blood sugar regulation and nutrient absorption. Currently, it can be medicated by using multiple gastroparesis drugs, including domperidone, Metoclopramide, Reglan, erythromycin, diphenhydramine, antiemetics, ondansetron, and prochlorperazine. These medications improve spasms in stomach muscles, enhance gastric emptying, and promote nutrition absorption; thus, gastroparesis drugs are recommended or prescribed by doctors to treat diabetes and other diseases.

What are the growth prospects and trends in the gastroparesis drugs industry?

The increasing prevalence of idiopathic gastroparesis, diabetes mellitus, and post-surgical gastroparesis is primarily driving the market growth. Moreover, the introduction of innovative drugs and treatments for avoiding symptoms such as nausea, abdominal pain, and vomiting is favoring the gastroparesis drug market. Furthermore, the significant rise in the geriatric population who are susceptible to gastroparesis due to sedentary lifestyles, extensive smoking, and consumption of alcoholic drinks are supplementing the product demand.

Moreover, the extensive investments by governments in research and development (R&D) activities to employ user-friendly approaches to formulate effective drugs for gastroparesis, is favoring the market growth. Other factors, such as the significant enhancements in the healthcare infrastructure, favorable reimbursement policies by regulatory bodies, and the growing consumer awareness regarding the availability of gastroparesis drugs on diverse shopping platforms, are contributing to the market growth.

Who are the key players operating in the industry?

The report covers the major market players including: 

Abbott Laboratories
Abbvie Inc
AstraZeneca Plc
Bausch Health Companies Inc
Becton Dickinson and Company
Boston Scientific Corporation
Evoke Pharma
Medtronic plc
Neurogastrx Inc.
Sanofi S.A
Takeda Pharmaceutical Company Limited
Theravance Biopharma 

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Disease Type:

Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others

Breakup by Drug Class:

Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections

Breakup by Distribution Channel:

Hospitals and Clinics
Pharmacies
Online Stores

Breakup by Region:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

 Ask Analyst for Customization and Explore full report with TOC & List of Figures:  https://www.imarcgroup.com/request?type=report&id=4608&flag=E

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Media Contact:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

About Us:                                                              

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.